Legend Biotech Corp Profit Loss Before Tax
Legend Biotech Corp (LEGN) reported Profit Loss Before Tax of -$282.60 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:ProfitLossBeforeTax · last filed 2026-03-10
- Legend Biotech Corp profit loss before tax for the quarter ending 2025-12-31 was -$19.60M, a 148.34% decline year-over-year.
- Legend Biotech Corp profit loss before tax for the quarter ending 2025-09-30 was -$39.07M.
- Legend Biotech Corp profit loss before tax for the quarter ending 2025-06-30 was -$124.80M.
- Legend Biotech Corp profit loss before tax for the quarter ending 2025-03-31 was -$99.13M.
| Period end | Profit Loss Before Tax 3 month | Profit Loss Before Tax 6 month | Profit Loss Before Tax 9 month | Profit Loss Before Tax 12 month | Profit Loss Before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$19.60M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$58.67M derived: sum of 2 quarters · filed 2026-03-10 | -$183.47M derived: sum of 3 quarters · filed 2026-03-10 | -$282.60M 20-F · filed 2026-03-10 | |
| 2025-09-30 | -$39.07M 6-K · filed 2025-11-12 | -$163.87M derived: sum of 2 quarters · filed 2025-11-12 | -$263.00M 6-K · filed 2025-11-12 | -$222.46M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-06-30 | -$124.80M 6-K · filed 2025-08-11 | -$223.93M 6-K · filed 2025-08-11 | -$183.38M derived: sum of 3 quarters · filed 2026-03-10 | -$304.27M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-03-31 | -$99.13M 6-K · filed 2025-05-13 | -$58.59M derived: sum of 2 quarters · filed 2026-03-10 | -$179.47M derived: sum of 3 quarters · filed 2026-03-10 | -$197.44M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-12-31 | $40.54M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$80.34M derived: sum of 2 quarters · filed 2026-03-10 | -$98.31M derived: sum of 3 quarters · filed 2026-03-10 | -$158.10M 20-F · filed 2026-03-10 | -$158.13M 20-F · filed 2025-03-11 |
| 2024-09-30 | -$120.89M 6-K · filed 2025-11-12 | -$138.86M derived: sum of 2 quarters · filed 2025-11-12 | -$198.64M 6-K · filed 2025-11-12 | -$345.54M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-06-30 | -$17.97M 6-K · filed 2025-08-11 | -$77.76M 6-K · filed 2025-08-11 | -$224.65M derived: sum of 3 quarters · filed 2026-03-10 | -$287.15M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-03-31 | -$59.79M 6-K · filed 2025-05-13 | -$206.68M derived: sum of 2 quarters · filed 2026-03-10 | -$269.18M derived: sum of 3 quarters · filed 2026-03-10 | -$468.01M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2023-12-31 | -$146.89M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$209.39M derived: sum of 2 quarters · filed 2026-03-10 | -$408.23M derived: sum of 3 quarters · filed 2026-03-10 | -$520.20M 20-F · filed 2026-03-10 | -$520.12M 20-F · filed 2024-03-19 |
| 2023-09-30 | -$62.49M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | -$261.33M derived: sum of 2 quarters · filed 2024-11-12 | -$373.31M 6-K · filed 2024-11-12 | -$509.03M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | -$198.84M derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | -$310.81M 6-K · filed 2024-08-09 | -$446.53M derived: sum of 3 quarters · filed 2025-03-11 | -$531.34M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | -$111.97M 6-K · filed 2024-05-13 | -$247.70M derived: sum of 2 quarters · filed 2025-03-11 | -$332.50M derived: sum of 3 quarters · filed 2025-03-11 | ||
| 2022-12-31 | -$135.72M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | -$220.53M derived: sum of 2 quarters · filed 2025-03-11 | -$445.72M 20-F · filed 2025-03-11 | ||
| 2022-09-30 | -$84.80M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | -$310.00M 6-K · filed 2023-11-20 | |||
| 2022-06-30 | -$225.20M 6-K · filed 2023-08-15 | ||||
| 2021-12-31 | -$407.20M 20-F · filed 2024-03-19 | -$386.21M 20-F · filed 2022-03-31 | |||
| 2021-06-30 | -$172.48M 6-K · filed 2021-08-23 | ||||
| 2020-12-31 | -$308.29M 20-F · filed 2023-03-30 | -$307.62M 20-F · filed 2021-04-02 | |||
| 2020-06-30 | -$182.81M 6-K · filed 2021-08-23 | ||||
| 2019-12-31 | -$127.32M 20-F/A · filed 2023-02-17 | -$130.37M 20-F · filed 2021-04-02 | |||
| 2018-12-31 | -$1.62M 20-F · filed 2021-04-02 |